Meldungen sortieren nach Relevanz Meldungsdatum
|
HealthCare Unternehmen setzen auf Online-Kompetenz von M.I.T e-Solutions
, Internet, M.I.T e-Solutions GmbH
Die Lahn-Dill-Kliniken aus Wetzlar und Novartis Vaccines and Diagnostics aus Marburg setzen beim Relaunch ihrer Websites auf die e-Marketing-Kompetenz von M.I.T...
|
Medical Diagnostics Company STAT-Diagnostica Secures 22.1 Million USD/17 Million Euros in Series B Financing
, Medizintechnik, STAT-DIAGNOSTICA & INNOVATION
STAT-Diagnostica has announced the closing of a Series B financing round totaling 22.1 Million USD/17 Million Euros, the proceeds of which will be used to complete...
|
BMZ-Staatssekretär Beerfeltz sagt 5 Millionen Euro für den Schutz von Polio-Impfhelfern zu
, FirmenIntern, Bundesministerium für wirtschaftliche Zusammenarbeit und Entwicklung
Vor dem Hintergrund wiederkehrender gewaltsamer und mehrerer tödlicher Angriffe auf Polio-Impfhelfer hat BMZ-Staatssekretär Hans-Jürgen Beerfeltz heute in Abu Dhabi...
|
ARTES Biotechnology issued New Patent in Australia for VLP Technology
, Biotechnik, ARTES Biotechnology GmbH
ARTES Biotechnology specialized in microbial cell line and process development as well as in technology transfer for pharmaceutical industry is pleased to announce...
|
Rodos BioTarget Receives Growth Financing of EUR 2.6 m
, Finanzen / Bilanzen, High-Tech Gründerfonds Management GmbH
Rodos BioTarget GmbH (RBT) is pleased to announce that it has in 2012 successfully realized corporate investment actions in the amount of EUR 2.6 million, with additional...
|
Early Results of Activartis AV0113 Cancer Immunotherapy in Glioblastoma Trial Reveal Promising Trend
, Forschung und Entwicklung, Activartis Biotech GmbH
Glioblastoma multiforme (GBM) is the most severe form of brain cancer and progresses rapidly. With the first-line treatment (surgery, chemo-, and radiotherapy) the...
|
Viral vectors for novel cell models, gene therapy and vaccine development gain further funds from private investors
, Biotechnik, SIRION BIOTECH GmbH
SIRION Biotech GmbH has won two additional private investors, one of them being Aumenta GmbH. Both contribute to a large extent to the current financing round side...
|
S-TARget Achieves In Vivo Proof of Concept for Its Allergy Vaccine SG100
, Biotechnik, S-TARget therapeutics GmbH
S-TARget therapeutics ("S-TARget"), a biotechnology company developing vaccines that address the cause of severe allergic diseases, announced today that it has achieved...
|
immatics' co-founder Professor Dr Hans-Georg Rammensee awarded the Bayer Hansen Family Award 2013
, Forschung und Entwicklung, immatics biotechnologies GmbH
immatics biotechnologies GmbH, a clinical-stage biopharmaceutical company developing advanced therapeutic vaccines that are active against cancer, announces today...
|
Riboxx Pharmaceuticals and China National Biotec Group Company Limited Initiate a Collaboration to Evaluate the Potential of Riboxxim®, a TLR3 Agonist, as Adjuvant in a Vaccine to Treat a Deadly Infectious Disease
, Kooperationen / Fusionen, Riboxx GmbH
Riboxx Pharmaceuticals GmbH (Riboxx) and China National Biotec Group Company Limited (CNBG) today announced that they have initiated a research collaboration to...
|
Dr. Jörg Reinhardt verlässt Bayer HealthCare
, FirmenIntern, Bayer AG
Dr. Jörg Reinhardt (56), Vorsitzender des Vorstands der Bayer HealthCare AG und Mitglied im Executive Council der Bayer AG, wird seinen im Sommer 2013 auslaufenden...
|
CEVEC Pharmaceuticals and Vakzine Projekt Management Sign Exclusive License Agreement on the Clinical Development of a Novel Human Cytomegalovirus (CMV) Vaccine
, Forschung und Entwicklung, CEVEC Pharmaceuticals GmbH
CEVEC Pharmaceuticals ("CEVEC"), the developer of the CAP® Technology, a novel human expression system derived from amniocytes, and VPM - Vakzine Projekt Management...
|
Sartorius Stedim Biotech Expands Portfolio by Adding Cell Culture Media
, FirmenIntern, Sartorius AG
. - Sartorius Stedim Biotech assumes global sales and marketing of media and buffer solutions for biopharmaceutical manufacture - Long-term collaboration, supply...
|
4SC Discovery and BioNTech announce exclusive research and license agreement for 4SC's TLR agonists for cancer immunotherapy
, Forschung und Entwicklung, 4SC AG
4SC AG (Frankfurt, Prime Standard: VSC), a discovery and development company of targeted small molecule drugs for autoimmune diseases and cancer, today announced...
|
Adeno-associated virus now easily available for research and preclinical studies.
, Biotechnik, PlasmidFactory GmbH & Co. KG
Munich, Bielefeld, Heidelberg (Germany), SIRION Biotech and PlasmidFactory agreed to actively promote adeno-associated virus (AAV) vectors for advanced preclinical...
Ähnliche Keywords
Firmen
Kategorien
- FirmenIntern (41)
- Biotechnik (30)
- Forschung und Entwicklung (23)
- Kooperationen / Fusionen (9)
- Medizintechnik (8)
Alle Kategorien
